A phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma.
about
Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens.A phase I-II study of docetaxel-ifosfamide-cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancer.Phase I-II study of docetaxel and ifosfamide combination in patients with anthracycline pretreated advanced breast cancerDocetaxel-ifosfamide combination in patients with advanced breast cancer failing prior anthracycline-based regimens: results of a phase I-II study.Evaluation of the paclitaxel-ifosfamide-cisplatin (TIP) combination in relapsed and/or metastatic cervical cancer.BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.Distinct patterns of angiogenic factor expression as a predictive factor of response to chemotherapy in stage IIIA non-small-cell lung cancer patients.Modulation of peripheral immune responses by paclitaxel-ifosfamide-cisplatin chemotherapy in advanced non-small-cell lung cancer.
P2860
Q33340278-F4E59F5C-C76B-4A9B-B2EF-0979754DB7D7Q33341156-CE2C398C-93CE-40E3-861B-79293602544FQ33347519-7BE43747-FAD7-4D87-94E5-3410F6C1DF1CQ33375702-FA59018F-DD0C-4543-A59C-99D5ABB904D5Q33386149-393DE75A-0D60-4B22-8331-C2AC997EE293Q35066071-C68B1EF0-1D1A-439E-AE6B-BFFC6D1BA3BFQ37288259-B6BF5AF2-00EB-4AA1-BAC1-EDE02ABABDDFQ45912169-4FECC1D7-83C2-4480-A1AA-B8ED4A3B1696
P2860
A phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
A phase II study of paclitaxel ...... nonsmall cell lung carcinoma.
@ast
A phase II study of paclitaxel ...... nonsmall cell lung carcinoma.
@en
A phase II study of paclitaxel ...... nonsmall cell lung carcinoma.
@nl
type
label
A phase II study of paclitaxel ...... nonsmall cell lung carcinoma.
@ast
A phase II study of paclitaxel ...... nonsmall cell lung carcinoma.
@en
A phase II study of paclitaxel ...... nonsmall cell lung carcinoma.
@nl
prefLabel
A phase II study of paclitaxel ...... nonsmall cell lung carcinoma.
@ast
A phase II study of paclitaxel ...... nonsmall cell lung carcinoma.
@en
A phase II study of paclitaxel ...... nonsmall cell lung carcinoma.
@nl
P2093
P2860
P1433
P1476
A phase II study of paclitaxel ...... d nonsmall cell lung carcinoma
@en
P2093
M J Antonopoulos
N A Malamos
N B Tsavaris
P2860
P304
P356
10.1002/1097-0142(20000815)89:4<774::AID-CNCR9>3.0.CO;2-5
P407
P577
2000-08-01T00:00:00Z